Current Setup & Catalysts
Current Setup & Catalysts
Current Setup in One Page
The stock is at a fresh all-time high of $640 (May 7, 2026 close) after a 695% twelve-month run, and the market is overwhelmingly watching one number: whether the Q3 FY2026 print on or about June 24, 2026 validates the company's own ~81% gross-margin guide, ~$33.5B revenue, and ~$19 non-GAAP EPS. The recent setup is unambiguously bullish — Q2 FY2026 was a 28% revenue beat, FY2026 consensus EPS roughly doubled in 90 days (from ~$33 to $58), and analyst targets fan from $520 to a Street-high $1,000 — but the calendar is dominated by a single hard date and one disputed live debate (Micron's actual HBM4 share at NVIDIA Vera Rubin) that the bull case rests on. The next 90 days carry one earnings print, the J.P. Morgan TMT conference on May 20, two CY2Q-2026 DRAM contract pricing rounds, and a series of insider 10b5-1 filings; everything truly thesis-resolving lands in late June. Beyond June, the path narrows to the Q4 FY2026 print (late September 2026), additional Strategic Customer Agreement (SCA) signings, and the HBM4E ramp into CY2027.
Recent setup: Bullish.
Hard-dated catalysts (6 mo)
High-impact catalysts
Days to next hard date
Last close ($)
Q3 FY26 consensus revenue ($B)
Q3 FY26 consensus EPS ($)
Single most important live event: Q3 FY2026 results, expected on or about June 24, 2026. Consensus has fully re-rated to management's own guide ($33.5B / 81% GM / ~$19 EPS); the next move is set by whether the print clears the guide, by whether Q4 FY26 commentary extends or compresses the run-rate, and by any HBM4 share or SCA disclosure on the call. With the stock at 95.5% of its 52-week range, the asymmetry on a sequential gross-margin slip below 70% is large.
What Changed in the Last 3-6 Months
The narrative arc since November 2025 has moved from "is this a real cycle?" to "how long can 70%-plus gross margins persist?" Three months ago the live debate was whether Q1 FY26's $4.78 EPS could plausibly extend into FY27; today the question is whether $19 quarterly EPS is the run-rate ceiling or the next stepping-stone. What the market has stopped worrying about: cycle direction, HBM3E qualification, FY26 visibility, China CAC tail risk, and the FY23-24 class-action overhang. What it has started worrying about: capex absorption in FY27, HBM4 share at Vera Rubin, the durability of one signed SCA into multiple, and CHIPS-restricted capital returns.
What the Market Is Watching Now
The live debate is no longer "is HBM real" but "is the second cycle real." With the FQ3 26 guide already roughly the highest revenue/margin combo any memory maker has ever printed, expectation-gap upside is narrowing — the more interesting trades come from items 2, 3, and 6 where consensus has converged but management has not yet been forced to disclose.
Ranked Catalyst Timeline
Impact Matrix
The matrix is concentrated by design: only six items resolve the live debate, and the first three are clustered inside the next six weeks. The remaining items (capital allocation, insider activity, technicals) shape position sizing more than directional thesis.
Next 90 Days
The 90-day window is dominated by one print. May 20 is the only meaningful preview window; the remaining 30 days through June 24 are sentiment / option-positioning rather than fundamentals. Beyond June 24, the next event of comparable weight is late September 2026 (FQ4 FY26 results, the first quarter where management is likely to extend FY27 commentary with numbers attached).
What Would Change the View
The two observable signals that would most decisively move the investment debate over the next six months are (1) the Q3 FY26 prepared remarks on HBM4 share at NVIDIA Vera Rubin and (2) any disclosure of a second multi-year SCA with a different counterparty. The first is the lynchpin of the bull's $100+ FY27 EPS path that the bear case argues is materially overstated by the disputed Korean-press supplier list; a sole-source confirmation to SK hynix or Samsung removes the largest HBM4 socket from MU's CY26-27 unit model and points to the bear's $400-$420 range, while a dual/triple-source confirmation closes the bear case on this leg. The second resolves the Bull/Bear/Forensic debate together — one signed SCA is hopeful, two across different counterparties shifts a meaningful slice of revenue from spot commodity to contract industrial, structurally lifts the trough-cycle gross-margin floor, and is the bear's explicit cover signal. A third, smaller-but-still-decisive signal is whether an NEO makes a meaningful open-market purchase post-print: it would not move the stock, but it would invalidate the only governance-shaped reason to discount the bull case. Everything else (capex, technicals, China exit, CXMT) shapes magnitude rather than direction.